Skip to main content
Clinical Trials/DRKS00023818
DRKS00023818RecruitingNot Applicable

Implementation and evaluation of mobile health tools for personalised follow-up of patients in radiation therapy for prostate cancer - PersoRad

niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde0 sites130 target enrollmentStarted: January 12, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
130

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to one (—)
Sex
Male

Inclusion Criteria

  • SUBSTUDY 1:
  • Prostate cancer patients under radiation with curative intent,
  • histologically proven PCA,
  • Gleason Score 6-9,
  • PSA <40 ng/ml.
  • SUBSTUDY 2:
  • Patients with primary prostate cancer of favorable-intermediate- to very-high risk after NCCN (National Comprehensive Cancer Network)
  • histologically proven PCA,
  • cT2a-3b (MRT, PET/CT),
  • cN0 und cM0 (MRT, PET/CT),
  • Gleason-Score 7-9,
  • ECOG Performance Status 0 or 1,
  • IPSS < 15,
  • size of prostate = 75 ml (as of date of radiation therapy planning)

Exclusion Criteria

  • SUBSTUDIES 1 and 2: insufficient command of German language, patient too much distressed by his condition, acute psychosis, risk of suicide present.

Investigators

Sponsor
niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde

Similar Trials